See also this year's filing and all EDGAR filings for this company.
PDF Report 0001399529_2018_Dicerna_Pharmaceuticals_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001399529')"} |
Graph
Absolute values for 0001399529, Dicerna Pharmaceuticals Inc
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 118,558,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 1,512,000 |
3 | remainder_Assets | 814,000 |
4 | LiabilitiesCurrent | 16,646,000 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 3,000,000 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 25,881,000 |
9 | ResearchAndDevelopmentExpense | 36,983,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 2,277,000 |
12 | remainder_NetIncome | 539,000 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 120,884,000 |
1 | Liabilities | 19,646,000 |
2 | Expenses | 62,864,000 |
3 | Revenues | 2,277,000 |
4 | StockholdersEquity | 101,238,000 |
5 | NetIncome | -60,048,000 |
6 | ComprehensiveNetIncome | -60,048,000 |
7 | BaseVar | 103,105,000 |
8 | EconomicCapitalRatio | 1.62 |